EasyDNNNewsCalendar

Archive

EasyDNNNews

Thursday, April 25, 2019

Genetic testing for newly diagnosed breast cancer patients could save $50M

Radiology Business (4/25) reports that results from the TAILORx clinical trial revealed that genetic testing could not only help a majority of women with HR-positive, HER2-negative, axillary node-negative breast cancer, but also lead to approximately $50 million in savings for the first year of breast cancer care in the United States.

Print
Author: Nicole Hardy
0 Comments

Categories: 2019, April, News, Screening and MammographyNumber of views: 1983

Tags: